Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodor H Lippert

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Deutsches Arzteblatt International|June 25, 2010
Resistance tests were not mentionedTheodor H Lippert
Deutsches Arzteblatt International|April 4, 2012
Correspondence (letter to the editor): Laboratory tests to ascertain tumor resistance to drugs are availableTheodor H Lippert
Maturitas|September 25, 2002
Estradiol metabolism and malignant diseaseAlfred O Mueck, Harald Seeger, Theodor H Lippert
Therapeutics and Clinical Risk Management|February 11, 2014
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?Theodor H Lippert, Hans-Jörg Ruoff, Manfred Volm
International Journal of Medical Sciences|April 14, 2011
Current status of methods to assess cancer drug resistanceTheodor H Lippert, Hans-Jörg Ruoff, Manfred Volm
Arzneimittel-Forschung|August 6, 2008
Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failureTheodor H Lippert, Hans-Jörg Ruoff, Manfred Volm
Hormone Research|December 4, 2003
Effects of oxytocin outside pregnancyTheodor H Lippert, Alfred O Mueck, Harald Seeger, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Deutsches Arzteblatt International|June 25, 2010
Resistance tests were not mentionedTheodor H Lippert
Deutsches Arzteblatt International|April 4, 2012
Correspondence (letter to the editor): Laboratory tests to ascertain tumor resistance to drugs are availableTheodor H Lippert
Maturitas|September 25, 2002
Estradiol metabolism and malignant diseaseAlfred O Mueck, Harald Seeger, Theodor H Lippert
Therapeutics and Clinical Risk Management|February 11, 2014
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?Theodor H Lippert, Hans-Jörg Ruoff, Manfred Volm
International Journal of Medical Sciences|April 14, 2011
Current status of methods to assess cancer drug resistanceTheodor H Lippert, Hans-Jörg Ruoff, Manfred Volm
Arzneimittel-Forschung|August 6, 2008
Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failureTheodor H Lippert, Hans-Jörg Ruoff, Manfred Volm
Hormone Research|December 4, 2003
Effects of oxytocin outside pregnancyTheodor H Lippert, Alfred O Mueck, Harald Seeger, et al.
Pageof 1